Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    edited by Connie Henke Yarbro, MS, RN, FAAN, Adjunct Clinical Associate Professor, ... Show More MU Sinclair School of Nursing, University of Missouri, Columbia, Columbia, Missouri, Editor, Seminars in Oncology Nursing, Destin, Florida, Debra Wujcik, PhD, RN, FAAN, AOCN, Oncology Consultant, Franklin, Tennessee, Barbara Holmes Gobel, MS, RN, AOCN, Associate Chief Nurse Executive, Director of Professional Practice and Development, Magnet Program Director, Northwestern Memorial Hospital, Chicago, Illinois, Adjunct Faculty, Rush University College of Nursing, Rush University Medical Center, Chicago, Illinois.
    Summary: "Cancer Nursing: Principles and Practice, Eighth Edition continues as the gold standard in oncology nursing. With contributions from the foremost experts in the field, it has remained the definitive reference on the rapidly changing science and practice of oncology nursing for more than 25 years. Completely updated and revised to reflect the latest research and developments in the care of patients with cancer, the Eighth Edition includes new chapters on the biology of cancer, sleep disorders, and palliative care across the cancer continuum.The Eighth Edition also includes significant updates to the basic science chapters to reflect recent increases in scientific knowledge, especially relating to genes and cancer. Also heavily revised are the sections devoted to the dynamics of cancer prevention, detection, and diagnosis, as well as treatment, oncologic emergencies, end of life care, and professional and legal issues for oncology nurses. In addition, it provides extensive and current information on breast cancer, including two separate chapters on early stage breast cancer and metastatic breast cancer, and careful attention to survivorship issues." [Jones & Bartlett Learning].

    Contents:
    pt. I: The cancer problem
    pt. II: Prevention, detection, and diagnosis
    pt. III: Treatment
    pt. IV: Cancer symptom management
    pt. V: Oncologic emergencies
    pt. VI: The care of individuals with specific cancers
    pt. VII: Dimensions of cancer survivorship
    pt. VIII: Palliative and end of life
    pt. IX: Professional issues for the cancer nurse.
    Digital Access R2Library 2018
    Limited to 1 simultaneous user
  • Article
    Ochs JJ, Freeman AI, Douglass HO, Higby DS, Mindell ER, Sinks LF.
    Cancer Treat Rep. 1978 Feb;62(2):239-45.
    Eight patients with advanced metastatic osteogenic sarcoma were treated with cis-dichlorodiammineplatinum(II) (DDP). Prior to DDP, seven patients had amputations and all had received adjuvant adriamycin (ADR) therapy. In addition, prior to DDP, six patients had received high-dose methotrexate. There was one complete response (pulmonary metastases) and four partial responses (three metastases in the lungs and one in the bone). One additional patient, with local recurrence of osteogenic sarcoma of the mandible following initial resection and adjuvant ADR, was retreated with surgery and DDP and is disease-free for greater than 3 years. The cumulative dose ranged from 300 to 660 mg/m2. Toxicity included irreversible kidney damage in two patients, transient severe hematologic suppression in two patients, and nausea and vomiting in all patients. DDP is a new effective agent in the treatment of osteogenic sarcoma.
    Digital Access Access Options